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ABSTRACT Two cases of angiotensin converting enzyme inhibitor fetopa- 
thy with renal tubular dysgenesis and severely underdeveloped calvarial bone 
are described. Six additional, unexposed cases of hypocalvaria are described, 
and possible links between calvarial development and fetal hypotension andlor 
chronic hypoxia are explored. 
The purposes of this paper are (1) to re- 
port two cases of angiotensin converting en- 
zyme (ACE) inhibitor fetopathy associated 
with a hypoplastic calvaria, (2) to explore 
possible pathogenetic ACE inhibiting links 
in the kidney-skull connection, and (3) to 
review briefly six other cases of hypoplastic 
calvaria together with their associated 
anomalies-most of unknown etiology. Be- 
fore presenting case reports and discussion, 
we summarize the physiology, pharmacol- 
ogy, and reported fetal effects of ACE inhib- 
itors. 
ACE INHIBITORS 
ACE inhibitors were developed from a 
serendipitous finding-Brazilian snake 
venom containing kinase-inhibiting factors 
(Ferreira, '65).  Basic scientists demon- 
strated its physiological relevance by estab- 
lishing the relationship between vasoactive 
peptide hormones and their enzymatic deg- 
radation (Yang et al., '70). 
All ACE inhibitors' have a common 2-me- 
thy1 propanalol-L-proline moiety. Captopril 
binds the enzyme by means of a sulfhydryl 
group; lisinopril does not. Proactive drugs 
were developed to increase the rate of re- 
sorption, to prolong the action of the active 
agent, or both. Enalapril is a proactive drug; 
it remains inactive until converted to an  ac- 
tive compound in the liver. The primary 
route of elimination of the ACE inhibitors is 
the kidney (Williams, '88). 
ACE inhibitors block the conversion of 
angiotensin I to angiotensin 11, thus in- 
creasing renin and, when measured, reduc- 
ing angiotensin I1 and aldosterone. The 
need for a higher replacement level of an- 
giotensin I1 to restore blood pressure after 
the administration of ACE inhibitors sug- 
gests that factors other than the fall in an- 
giotensin I1 may be responsible for reduc- 
tion in blood pressure (Swartz et al., '79). 
The relationship of ACE inhibitors to 
bradykinin degradation and to prostaglan- 
din production is unresolved. The effects on 
these two hormones may occur a t  the tissue 
level without significant change in blood 
levels (Williams, '88). 
ACE inhibitors have several advantages 
in treating hypertension. Most antihyper- 
tensive agents (e.g., diuretics and p-adren- 
ergic receptor blockers) tend to elevate pe- 
ripheral resistance and have a n  effect on the 
metabolism of glucose, lipids, and electro- 
lytes. In contrast, ACE inhibitors decrease 
vascular resistance with no known adverse 
metabolic consequences (Williams, '88; 
Gavras, '88). In the absence of heart failure, 
little change in heart rate, cardiac output, 
or pulmonary wedge pressure is experienced 
in normal or hypertensive subjects taking 
-- 
'Commonly used ACE inhibitors include captopril, enalapril, 
and lisinopril. However, other drugs are known such as ramipril, 
cilazapril, pentopril, and alacepril. 
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ACE inhibitors (Vidt et al., '82; Todd and 
Heel, '86; Gomez et al., '87). It is now known 
that ACE inhibitors are an effective form of 
treatment for all stages of hypertension and 
some authors have suggested that ACE in- 
hibitors are the preferred agents for the 
treatment of hypertension (Sassano et al., 
'87). Thus, we can expect greater use of ACE 
inhibitors in the future. 
When ACE inhibitors have been admin- 
istered during pregnancy, a number of cases 
have been reported with fetal wastage 
(Kreft-Jais et al., '88) and adverse late fetal 
and neonatal outcomes such as fetal anoxia, 
intrauterine growth retardation, oligohy- 
dramnios, postnatal anuria, Potter se- 
quence, and respiratory distress (Guignard 
et al., '81; Rothberg and Lorenz, '84; Knott 
et al., '89; Schubiger et al., '88; Rosa et al., 
'89; Scott and Purohit, '89). Renal tubular 
dysgenesis associated with enalapril expo- 
sure was reported by Cunniff et al. ('90) and 
they noted the similarity to a genetic reces- 
sive form of tubular dysgenesis (Allanson et 
al., '83; Voland et al., '85; Bernstein, '88; 
Swinford et al., '89). 
Less commonly reported ACE inhibitor 
exposure effects have included a hypoplastic 
calvaria (Duminy and Burger, '81; Mehta 
and Moda, '89; Rothberg and Lorenz, '84.) 
This defect is of particular concern because 
the fetal brain, inadequately protected by 
skull bone, could be severely traumatized 
during passage through the birth canal. 
CASEREPORTS 
Case #I 
The mother, a 26-year-old G,P,, had sys- 
temic lupus erythematosus with nephro- 
genic hypertension of 8 years duration man- 
aged successfully with prednisone, atenolol, 
furosemide, and captopril. From 20 weeks 
gestation, serial ultrasound examinations 
showed unrelieved oligohydramnios, nonvi- 
sualization of the fetal bladder, and mild 
growth retardation. At 33 weeks a 1.44-kg 
girl was delivered. Apgar scores were one 
and five at 1 and 5 min, respectively. De- 
spite maximal ventilatory support there 
was persistent acidosis and hypoxia. No 
urine was produced in the 14 hr before 
death. Autopsy showed pulmonary hypopla- 
sia and deformations resulting from oligo- 
hydramnios. There was calcified thrombosis 
of the inferior vena cava with bilateral ex- 
tension into the renal veins. Infradiaphrag- 
matic venous return to  the heart was via an 
enlarged azygous vein. The kidneys were 
large and showed renal tubular dysgenesis 
on microscopic examination (Fig. 1). The 
ureters and bladder were small but patent. 
The calvarial bones were of normal con- 
figuration but very small, leaving the top 
third of the head unprotected by bone (Fig. 
2). The wide "sutures" and "fontanels" con- 
sisted of relatively avascular, white fibrous 
tissue. The cranial base was unremarkable 
on gross inspection. A 2-cm coronal strip of 
calvarial bone beginning at the medial edge 
of the parietal bone was removed, decalci- 
fied, and stained with hematoxylin and 
eosin. The histology is illustrated in Figure 
5A and compared to normal calvarial bone 
(Fig. 5B). The bone is remarkably thin with- 
out adequate trabeculation or marrow de- 
velopment in contrast to control calvarial 
bone. 
Case #2 
The mother, an 18-year-old primigravida, 
had essential hypertension of 10 years du- 
ration, successfully managed with lisino- 
pril. The pregnancy was reportedly unre- 
markable with no suspicion of problems 
until the onset of labor at 32-33 weeks of 
gestation. After an unsuccessful trial of to- 
colysis, a 1.48-kg male infant was delivered 
by cesarean section, with Apgar scores of 
four and seven at 1 and 5 min, respectively. 
Persisting respiratory distress required the 
use of mechanical ventilation and the evac- 
uation of bilateral pneumothoraces. How- 
ever, his respiratory status improved and 
the respirator was discontinued on day 2 of 
life. 
From the time of birth to his transfer to 
the University of Michigan Medical Center 
at 8 days of age, there was no urine output. 
The kidneys were of normal size by ultra- 
sonography, but no perfusion was demon- 
strated on renal scan. Fluid and furosemide 
challenges did not result in urine output. 
After 2 weeks on peritoneal dialysis, he be- 
gan to pass small amounts of dilute urine. A 
renal biopsy was obtained at  1 month of age 
(Fig. 3). His urine volume increased over 
the next several weeks, but at age 15 
months he continues to be dependent on 
peritoneal dialysis and is awaiting renal 
transplantation. 
In the neonatal period, the fontanels were 
described as large and the sutures were said 
to be wide. On examination at  1 month of 
age, the skull plates were small but of ap- 
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Fig. 1. Section of kidney (Case 1) showing dilation of glomerular spaces, convoluted tu- 
bules, and collecting ducts. There is poor to no differentiation between proximal and distal 
convoluted tubules and intertubular mesenchyme appears to be increased. (Trichrome stain. 
Original magnification x 100.) 
Fig. 2. Skull and brain viewed from above (Case 1). The tissue comprising the fontanels 
and sutural regions has been removed, leaving only the calvarial bone, to demonstrate the 
diminutive size of the bones in hypocalvaria. 
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Fig. 3. Renal biopsy a t  1 month of age (Case 2) showing dilated glomerular spaces. Also 
seen are a dilated collecting duct, some dilated tubules, and poor differentiation between 
proximal and distal convoluted tubules. In other areas of the biopsy specimen, the prior 
existence of glomeruli and tubules was indicated only by collapsed rings of basement mem- 
brane. (Trichrome stain. Original magnification x 200.) 
propriate configuration. The midpoint 
width of the various sutures were: sagittal 3 
cm, coronals 3 cm, lambdoidals 2 cm, me- 
topic 2 cm, squamosal < 2 mm. The anterior 
fontanel measured 6 cm (long) by 4 cm 
(wide) and the posterior fontanel was 4 by 4 
cm. During the ensuing months, consider- 
able expansion of the calvarial bones was 
evident, and by 3 months of age the metopic, 
coronal, and lambdoidal sutures were less 
than 0.5 cm wide, the sagittal suture had 
narrowed to 1.5 cm, and there was a corre- 
sponding reduction in the size of the fon- 
tanels. 
Case #3 
The mother was a 26-year-old primi- 
gravida with Melnick-Needles syndrome. 
Third trimester ultrasonographic examina- 
tion showed oligohydramnios, intrauterine 
growth retardation, and multiple anoma- 
lies. Labor was stimulated by prostaglan- 
dins for a worsening biophysical profile, 
and a 36-week, 1403-gm male stillborn 
with multiple anomalies and ambiguious 
genitalia was delivered from the breech 
position. The placenta was dysmature with 
chorangiosis, amnion nodosum, stem vil- 
lous edema, and a cord length of 25 cm. 
Autopsy findings, summarized briefly in 
Table 1, were diagnostic of male Melnick- 
Needles syndrome. Hypocalvaria was an 
associated finding, the top one-third of the 
brain being unprotected by bone (Fig. 4). A 
2-cm coronal strip of calvarial bone begin- 
ning at the most medial edge of the parietal 
bone was removed, decalcified, and stained 
with hematoxylin and eosin. The histology 
is shown in Figure 5C and compared to 
normal calvarial bone (Fig. 5B). The bone is 
thinner than normal calvarial bone and is 
highly irregular, exhibiting an abnormal 
network pattern, many reversal lines, and 
inadequate marrow formation. 
ACE INHIBITOR FETOPATHY AND HYPOCALVARIA 489 
TABLE 1 .  Known cases with hypocaluaria and acaluaria 
Striking features Etiology Reference 
Hypocalvaria, oligohydramnios, postnatal ACE inhibitory effects Barr and Cohen, Case 1 _ _  
anuria, renal t;bdar dysgenesis, 
contractures of elbows and wrists, talipes 
calcaneovalgus, rockerbottom feet 
Hypocalvaria (resolving), postnatal anuria, 
renal tubular dysgenesis, respiratory distress 
(resolved), survival a t  15 months with severe 
renal dysfunction 
Hypocalvaria, left leg ended a t  midthigh 
Hypocalvaria, oligohydramnios, Potter 
sequence, contractures of elbows, knees, and 
ankles 
Hypocalvaria, oligohydramnios, postnatal 
anuria, intrauterine growth restriction, 
contractures of ankles, hips, and elbows 
Hypocalvaria, renal cystic dysplasia, 
arhinencephaly, small dysplastic eyeglobes, 
ocular hypertelorism, cleft palate, 
micrognathia, ear anomalies, defects of long 
bones, vertebrae, and ribs; omphalocele, 
abnormal genitalia (46,XY) 
Hypocalvaria, massive hydrops, nuchal cystic 
hygroma, ocular hypertelorism, short nose, 
micrognathia, brachydactyly, 
brachymetacarpalism, brachymetatarsalism, 
postaxial polydactyly (left foot), coarctation 
of the aorta, persistent left superior vena 
cava, Meckel diverticulum of the ileum, 
46,XY 
Hypocalvaria, oligohydramnios, intrauterine 
growth restriction, pulmonary hypoplasia, 
short nose, low-set, posteriorly rotated ears, 
short sternum 
Hypocalvaria, macrocephaly, hypotrophic legs, 
Hypocalvaria, oligohydramnios, ocular 
small lungs, small thymus 
hypertelorism, bilateral cleft lip and palate, 
microtia, transverse terminal deficiency of 
fingers and toes, preaxial polydactyly (left 
hand), cleft sternum, omphalocele, scoliosis, 
unilateral testicular agenesis, coarctation of 
the aorta, hydrocephaly 
palpebral fissures, short nose, rounded upper 
lip, low-set ears, short neck, contractures of 
elbows, thumbs, and knees, brachydactyly 
Acalvaria, alobar holoprosencephaly, ocular 
hypertelorism, oblique facial clefting, cleft 
lip and palate, low-set, malformed ears 
Acalvaria, absent orbital floors, cleft lip, 
metatarsus varus 
Hypocalvaria, oligohydramnios, upslanted 
(captopril) 
ACE inhibitory effects Barr and Cohen, Case 2 
(lisinopril) 
ACE inhibitory effects 
ACE inhibitory effects 
Duminy and Berger ('81) 
Mehta and Moda ('89) 
(captopril) 
(enalapril) 
ACE inhibitory effects Rothberg and Lorenz ('84) 
(captopril) 









Barr and Cohen, Case 4 
Barr and Cohen, Case 5 
Barr and Cohen, Case 6 
Barr and Cohen, Case 7 
Barr and Cohen, Case 8 
Unknown Sperber et  al. ('86) 
Unknown Mannes et al. ('82) 
Acalvaria Unknown Vergani et al. ('87) 
Case #4 
A 39-year-old G,PoAb, woman carried a 
fetus with marked hydrops shown on ultra- 
sonography a t  9 weeks. Chorionic villus 
sampling at  10 weeks showed a 46,XY kary- 
otype. Elective termination was carried out 
a t  15 weeks by prostaglandin induction. The 
137-gm fetus was characterized by marked 
generalized hydrops, bilateral cystic hy- 
groma, and multiple anomalies summarized 
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Fig. 4. Skull and brain viewed from the left (Case 3, Melnick-Needles syndrome). As in 
Figure 2, the tissue comprising the fontanels and intersutural regions has been removed to 
demonstrate the dirninutize size of the calvarial bones and the unprotected state of the brain. 
in Table 1. The top one-third of the brain 
was uncovered by bone. All sutures, includ- 
ing the squamosal, were split; the midsag- 
gital width was 15.0 mm. 
Case #5 
A 30-year-old G3P,Ab2 woman showing 
an increase in maternal serum a- 
fetoprotein was referred for ultrasonogra- 
phy. Severe oligohydramnios, fetal brady- 
cardia, and no fetal motion were evident. 
Elective termination by prostaglandin in- 
duction produced an 80-gm fetus whose fea- 
tures are listed in Table 1. The skull plates 
were small, leaving the top half of the brain 
uncovered by bone. The distance between 
the frontal apices was 2.5 cm; distance be- 
tween anterior parietal apices, 2.5 cm; dis- 
tance between posterior parietal apices, 2.0 
em; frontal bone height, 2.0 em; parietal 
height, 2.5 cm; and occipital bone height, 
1.5 cm. Karyotype was 46,XX. 
Case #6 
A 27-year-old G2P, woman with a history 
of no fetal motion for 2 weeks and fetal 
death confirmed by ultrasonography re- 
quested induction of delivery at 27 weeks. 
The 133-gm female fetus (20 week size) was 
macerated with considerable distortion of 
all body parts. Macrocephaly with hypoplas- 
tic calvarial plates was evident. Other find- 
ings are listed in Table 1. 
Case #7 
A 33-year-old GIPl woman with cleido- 
cranial dysplasia was referred for fetal ul- 
trasonography because of an elevated ma- 
ternal serum a-fetoprotein. The fetus was 
hydropic and had an  omphalocele and other 
less well-defined anomalies. The patient 
elected to have the pregnancy terminated 
by prostaglandin induction and a 56.4-gm 
male fetus was delivered at 17 weeks gesta- 
tion. Hypoplastic calvarial bones were evi- 
dent in addition to other anomalies listed in 
Table I. Attempts to grow fetal cells for 
karyotyping were unsuccessful. 
Case #8 
A 31-year-old GllP,Ablo woman was 
found a t  19.6 weeks gestation to have an 
elevated maternal serum a-fetoprotein, oli- 
gohydramnios, and severe fetal growth de- 
lay. Ovulation had been induced with clo- 
miphene, and immunotherapy with her 
husband’s leukocytes had been adminis- 
tered. The patient elected to terminate the 
pregnancy by prostaglandin induction, and 
a 68.8-gm female fetus was delivered. Hy- 
pocalvaria and other anomalies, listed in 
Table I, were found. The products of five of 
her prior miscarriages had been karyo- 
typed: four were normal and one was trip- 
loid. No karyotype could be obtained from 
this fetus. 
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DISCUSSION 
Nomenclature: hypocalvaria 
Acrania usually refers to absence of the 
calvaria with the cranial base present. It is 
commonly distinguished from anencephaly 
because it is not a neural tube defect, al- 
though the brain may be abnormal in some 
cases (Mannes et al., ’82; Vergani et al., ’87). 
However, the term acrania is inaccurate be- 
cause it implies involvement of both the cal- 
varia-which is composed of membrane 
bones-and the cranial base-which is pre- 
formed in cartilage. 
We propose the following terms which we 
think more accurately describe our observa- 
tions. We introduce the term hypocalvaria 
to mean hypoplasia of the membrane bones 
of the skull. The finding of hypoplastic cal- 
variae of different types in ACE inhibitor 
and Melnick-Needles fetopathies indicates 
that  hypocalvaria is both etiologically and 
pathogenetically heterogeneous. Our pro- 
posed term is also flexible enough to de- 
scribe the defect independently of whether 
the brain is normal or abnormal or whether 
the cartilaginous cranial base is normal or 
abnormal. Acalvaria,2 referring to aplasia of 
the membrane bones of the skull, appar- 
ently occurs much less commonly than hy- 
pocalvaria. Although we have not observed 
a case, we are aware of three instances in 
the literature (Sperber et al., ’86; Mannes et 
al., ’82; Vergani et al., ’87) and these find- 
ings are summarized in Table 1. 
Although references in the literature to 
the condition we are calling hypocalvaria 
are few, we suspect the condition may not be 
all that uncommon. It seems probable that 
many cases would be classified as huge fon- 
tanels with widely split sutures but in in- 
stances in which appropriate degrees of 
macrocephaly are not present. Our standard 
is that the calvarial bones are absolutely 
small for age; lacking age-specific morpho- 
metrics, this is a somewhat subjective as- 
sessment. 
The calvaria may also be defective with 
craniotabes. Prolonged vertex positioning 
results in compression and resorption of the 
top of the calvaria. Craniotabes is easily dis- 
tinguishable from hypocalvaria. Craniota- 
betic defects may be quite large, ovoid in 
‘The term was introduced by Sperber et al. (‘86). They pre- 
ferred “acalvaria” to “acrania,” indicatlng also that the latter 
term incorrectly implles absence of the entire cranium. 
shape, and asymmetrically placed. The 
edges feel smooth to clinical palpation; the 
central area feels soft because of absent 
bone. Craniotabes need not necessarily re- 
sult from prolonged vertex positioning; it 
may occur with any form of intrauterine 
compression and is an  occasional feature of 
the oligohydramnios (Potter) sequence. 
Hypocalvaria is also easily distinguished 
from cranial defects that may occur with 
aminopterin or methotrexate embryopathy, 
Saethre-Chotzen syndrome, hydrolethalus 
syndrome, or cranium bifidum with large 
parietal foramina (see Gorlin et al., ’90; Lit- 
tle et al., ’90). 
In hypophosphatasia, the calvarial bones 
are normal in size and shape, but are  com- 
posed of osteoid with minimal-to-absent cal- 
cification in the lethal form of the disorder. 
In the infantile form, the cranial sutures ap- 
pear widened radiographically. In achon- 
drogenesis, the skull is poorly mineralized 
in Types I (Houston-Harris) and I1 (Frac- 
carol and occipital defects occur in Types I1 
(Fraccaro), 111 (Langer-Saldino, severe), 
and IV (Langer-Saldino, mild) (see Gorlin 
et al., ’90). 
Pathogenetic aspects of hypocalvaria and 
the kidney-skull connection 
The cause of the hypoplastic calvaria 
found with ACE inhibitor exposure is un- 
known. Endochondral bone and membrane 
bone grow and develop in entirely different 
ways. Long bones require low oxygen ten- 
sion because nutrition takes place by diffu- 
sion through the cartilaginous epiphyses. 
Membrane bones, on the other hand, have 
the high degree of vascularity necessary for 
their own growth, and high oxygen tension 
is required. The presumed hypotension pro- 
duced by ACE inhibitor exposure may re- 
sult in hypoxic effects and thus a hypoplas- 
tic calvaria. 
Secondary cartilage has been found at- 
tached to the edges of normal calvarial 
bones on occasion (Pritchard et al., ’56). In 
avian experiments, i t  can be induced by hy- 
poxia and by mechanical factors (Hall, 
’67a,b). However, no secondary cartilage 
was found on histologic examination of the 
calvaria in Cases 1 and 3, the only ones to be 
examined microscopically. 
With presumptive hypotension and hy- 
poxia from ACE inhibition, ischemia was 
responsible for intracranial hemorrhage in 
one case (Mehta and Modi, ’89) and enceph- 
Fig. 5A and B. 
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Fig. 5. Skull histology of hypocalvaria. Each section was prepared from a strip of bone 
beginning a t  the medial edge of the parietal bone. (A) Case 1 (ACE inhibitor exposure, 33 
weeks gestation): the bone is thin without adequate trabeculation or marrow development. (B) 
Normal fetus (33 week gestation) for comparison. (C) Case 3 (Melnick-Needles syndrome, 36 
weeks gestation): the bone is thin and highly irregular, exhibiting an abnormal network 
pattern, many reversal lines, and inadequate marrow formation. (H&E stain. Original mag- 
nification x 100.) 
aloclastic prosencephaly in another (Seila- 
nian, '90). Both of these instances were also 
associated with hypocalvaria. 
One known effect of ACE inhibition is on 
the renal microvasculature at the level of 
the efferent arterioles. A kidney-skull con- 
nection may exist if (1) generalized hypoten- 
sion produces simultaneous but indepen- 
dent hypoxic effects in the kidney and the 
calvarial bones or (2) the vessels of the 
glomeruli and the calvaria react similarly 
to ACE inhibition. 
ACE is widely distributed in the body; it 
has been found in soluble form in body flu- 
ids and in membrane-bound form in arterial 
endothelial cells within and outside the pul- 
monary circulation, in epithelial cells with 
brush borders (placenta, kidney, intestine, 
and choroid plexus), in neuroepithelial cells, 
and in the male genital tract (testis, pros- 
tate, and epididymis) (Erdos and Skidgel, 
'87). To our knowledge, osteoblasts have not 
been studied. If present, it is conceivable 
that ACE inhibitors may act on one or more 
osteoblast-derived growth factors (IGF-I, 
IGF-11, TGF-P1, PDGF, and bFGF)3 thereby 
diminishing their autocrinelparacrine ac- 
tions. 
31GF-I, insulin-like growth factor-I; IGF-11, insulin-like 
growth factor-11; TGF-p1, transforming growth factor-pl; PDGF, 
platelet-derived growth factor; bFGF, basic fibroblast growth 
factor (Mohan and Baylink, '90). 
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The features of ACE inhibitor fetopathy, 
including anuria-oligohydramnios, renal 
tubular dysgenesis, and hypocalvaria, sug- 
gest that the underlying pathogenetic 
mechanism is fetal hypotension. For each of 
our eight cases of hypocalvaria a case can be 
made for the existence of in utero hypoten- 
sionlhypoxia, based on the morphologic 
findings and/or evidence of fetal growth re- 
striction. In the ACE inhibitor-exposed 
cases, the renal lesion is similar to, if not 
identical with, that seen in both the genetic 
recessive form of tubular dysgenesis and 
ischemic renal injury. To determine how 
specific this renal lesion is, work is eur- 
rently under way to examine the kidneys of 
other fetuses with presumed hypotension 
and/or chronic hypoxia. Additionally, if 
chronic fetal hypoxia is present, blood flow 
to the brain, heart, and kidneys might be 
preferentially spared a t  the expense of cir- 
culation to acral regions such as the limbs. 
If that is correct, such hypoxic fetuses 
should manifest differential growth restric- 
tion of the limbs. Our preliminary data sug- 
gest that relative shortness of the limbs, 
particularly the arms, is found under these 
circumstances. This line of investigation is 
also being pursued. 
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